XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Deficit (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2021
Mar. 22, 2020
Stockholders' Deficit [Line Items]    
Balance [1] $ (3,300,405)  
Net income 117,761 $ 121,602
Balance $ (3,236,080)  
Common Stock [Member]    
Stockholders' Deficit [Line Items]    
Balance (in shares) 38,868,350 38,934,009
Balance $ 389 $ 389
Issuance and cancellation of stock awards, net (in shares) (2,755) 1,645
Tax payments for restricted stock upon vesting, (in shares) (2,791) (5,929)
Purchases of common stock, (in shares) (65,870) (271,064)
Purchases of common stock $ (1) $ (3)
Exercises of stock options, (in shares) 21,263 380,938
Exercises of stock options   $ 4
Balance (in shares) 38,818,197 39,039,599
Balance $ 388 $ 390
Additional Paid-in Capital [Member]    
Stockholders' Deficit [Line Items]    
Balance 5,122 243
Tax payments for restricted stock upon vesting (1,044) (1,796)
Purchases of common stock (6,363) (988)
Exercises of stock options 3,693 10,101
Non-cash equity-based compensation expense 5,204 4,914
Balance 6,612 12,474
Retained Deficit [Member]    
Stockholders' Deficit [Line Items]    
Balance (3,303,492) (3,412,649)
Net income 117,761 121,602
Dividends declared on common stock and equivalents (36,475) (30,442)
Purchases of common stock (18,636) (78,599)
Adoption of credit losses standard   1,102
Balance (3,240,842) (3,398,986)
Accumulated Other Comprehensive Income (Loss) [Member]    
Stockholders' Deficit [Line Items]    
Balance (2,424) (3,742)
Currency translation adjustment 186 (2,326)
Balance $ (2,238) $ (6,068)
[1] The balance sheet at January 3, 2021 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.